About
TMClear is a privately held biotech company collaborating with the University of Utah to develop novel drug candidates for wide-angle glaucoma and neuro-protective therapies addressing unmet clinical needs in ophthalmology.
Explore TMClear's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.